| 臺大學術典藏 |
2020-11-19T03:19:23Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J.; Liu C.-J.; Chang J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B. |
| 臺大學術典藏 |
2020-11-03T08:19:41Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Kao J.-H.; Chen D.-S.; Chen P.-J.; Tseng T.-C.; Su T.-H.; Liu C.-J.; CHEN-HUA LIU; Yang S.-S.; Peng C.-Y.; Lin W.-T. |
| 臺大學術典藏 |
2020-11-03T08:19:40Z |
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-11-03T08:19:39Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
CHEN-HUA LIU; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-10-14T07:24:43Z |
Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy
|
Kao J.-H.; Yang S.-S.; Huang Y.-W.; Hsu C.-K.; Lin S.-C.; SHU-CHEN WEI; Hu J.-T.; Chang H.-Y.; Liang C.-W.; Chen D.-S.; Chen P.-J.; Hsu P.-N. |
| 臺大學術典藏 |
2020-09-30T03:22:22Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H. |
| 臺大學術典藏 |
2020-08-11T08:36:42Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; PO-CHIN LIANG; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Po-Chin Liang;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Huo T.-I.; Liao L.-Y.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Lu S.-N. |
| 臺大學術典藏 |
2020-06-22T07:37:12Z |
SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction
|
Yang S.-S.;Lo Y.-F.;Wu C.-C.;Shu-Wha Lin;Yeh C.-J.;Chu P.;Sytwu H.-K.;Uchida S.;Sasaki S.;Lin S.-H.; Yang S.-S.; Lo Y.-F.; Wu C.-C.; SHU-WHA LIN; Yeh C.-J.; Chu P.; Sytwu H.-K.; Uchida S.; Sasaki S.; Lin S.-H. |
| 臺大學術典藏 |
2020-06-22T07:37:11Z |
Severe metabolic acidosis causes early lethality in NBC1 W516X knock-in mice as a model of human isolated proximal renal tubular acidosis
|
Lo Y.-F.;Yang S.-S.;Seki G.;Yamada H.;Horita S.;Yamazaki O.;Fujita T.;Usui T.;Tsai J.-D.;Yu I.-S.;Shu-Wha Lin;Lin S.-H.; Lo Y.-F.; Yang S.-S.; Seki G.; Yamada H.; Horita S.; Yamazaki O.; Fujita T.; Usui T.; Tsai J.-D.; Yu I.-S.; SHU-WHA LIN; Lin S.-H. |
| 臺大學術典藏 |
2020-06-22T07:37:09Z |
Impaired phosphorylation of Na +-K +-2Cl - cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome
|
Lin S.-H.;Yu I.-S.;Jiang S.-T.;Shu-Wha Lin;Chu P.;Chen A.;Sytwu H.-K.;Sohara E.;Uchida S.;Sasaki S.;Yang S.-S.; Lin S.-H.; Yu I.-S.; Jiang S.-T.; SHU-WHA LIN; Chu P.; Chen A.; Sytwu H.-K.; Sohara E.; Uchida S.; Sasaki S.; Yang S.-S. |
